PEGylated Nanocarriers
Applications in Drug Delivery
- 1st Edition - April 1, 2027
- Latest edition
- Editor: Prashant Kesharwani
- Language: English
PEGylated Nanocarriers: Applications in Drug Delivery explores the essential properties of PEG that contribute to the creation of long circulating nanocarriers while also examin… Read more
Description
Description
PEGylated Nanocarriers: Applications in Drug Delivery explores the essential properties of PEG that contribute to the creation of long circulating nanocarriers while also examining the significant biological and pharmacological impacts of PEGylation and extended circulation. The book provides a detailed review of the preparation, properties, and applications of various long-circulating PEGylated nanocarriers, such as liposomes, nanoparticles, dendrimers, carbon nanotubes, and more. Key chapters also include analysis of the challenges, biological toxicity, and safety issues associated with PEGylated nanocarriers, enabling better clinical translation.
This book will be of interest to researchers and academics in the fields of biomaterials, pharmaceutical science, and polymer science who have an interest in developing PEGylated drug delivery systems for therapeutics.
This book will be of interest to researchers and academics in the fields of biomaterials, pharmaceutical science, and polymer science who have an interest in developing PEGylated drug delivery systems for therapeutics.
Key features
Key features
- Explores PEGylated liposomes, nanoparticles, dendrimers, and nanotubes, detailing their synthesis, properties, and drug delivery applications
- Covers pharmacokinetics, toxicity, immunogenicity, and regulatory challenges for safe and effective PEGylated drug delivery systems
- Highlights PEGylated nanocarriers’ role in improving solubility, controlled drug release, in vaccines, and in gene delivery
Readership
Readership
Researchers and academics in the fields of biomaterials, pharmaceutical science, and polymer science, with an interest in developing PEGylated drug delivery systems for therapeutics
Table of contents
Table of contents
1. History, Introduction, Basic Method and Types of PEGylation
2. Advantages, Disadvantages and Applications PEGylated Nanocarriers
3. Solubility Enhancement and Drug Release Mechanism by PEGylated Nanocarriers
4. Biofate, Cellular Interactions and Pharmacokinetics of PEGylated Nanocarriers
5. Synthesis and production approaches of pegylated nanocarriers
6. Biological Toxicity, Environmental Hazards Associated and Regulatory Aspects Associated with PEGylated Nanocarriers
7. PEGylated Liposomes: Revolutions in Advanced Drug Delivery
8. PEGylated Nanoemulsions: Revolutions in Advanced Drug Delivery
9. PEGylated Nanomicelles: Revolutions in Advanced Drug Delivery
10. PEGylated Chitosan Nanoparticles: Revolutions in Advanced Drug Delivery
11. PEGylated PLGA Nanoparticles: Revolutions in Advanced Drug Delivery
12. PEGylated Serum Albumin Nanoparticles: Revolutions in Advanced Drug Delivery
13. PEGylated Dendrimers: Revolutions in Advanced Drug Delivery
14. PEGylated Carbon Nanotubes: Revolutions in Advanced Drug Delivery
15. PEGylated Cerium Oxide Nanoparticles: Revolutions in Advanced Drug Delivery
16. PEGylated Silica Nanoparticles: Revolutions in Advanced Drug Delivery
17. PEGylated Gold Nanoparticles: Revolutions in Advanced Drug Delivery
18. PEGylated Silver Nanoparticles: Revolutions in Advanced Drug Delivery
19. PEGylated Magnetic Nanoparticles: Revolutions in Advanced Drug Delivery
20. PEGylated Nanocarriers: A New Frontier in Vaccine Delivery
21. PEGylated Nanocarriers: A New Frontier in Gene Delivery
22. Regulatory Concerns, Future Prospects and Concluding Remarks of PEGylated Nanocarriers
2. Advantages, Disadvantages and Applications PEGylated Nanocarriers
3. Solubility Enhancement and Drug Release Mechanism by PEGylated Nanocarriers
4. Biofate, Cellular Interactions and Pharmacokinetics of PEGylated Nanocarriers
5. Synthesis and production approaches of pegylated nanocarriers
6. Biological Toxicity, Environmental Hazards Associated and Regulatory Aspects Associated with PEGylated Nanocarriers
7. PEGylated Liposomes: Revolutions in Advanced Drug Delivery
8. PEGylated Nanoemulsions: Revolutions in Advanced Drug Delivery
9. PEGylated Nanomicelles: Revolutions in Advanced Drug Delivery
10. PEGylated Chitosan Nanoparticles: Revolutions in Advanced Drug Delivery
11. PEGylated PLGA Nanoparticles: Revolutions in Advanced Drug Delivery
12. PEGylated Serum Albumin Nanoparticles: Revolutions in Advanced Drug Delivery
13. PEGylated Dendrimers: Revolutions in Advanced Drug Delivery
14. PEGylated Carbon Nanotubes: Revolutions in Advanced Drug Delivery
15. PEGylated Cerium Oxide Nanoparticles: Revolutions in Advanced Drug Delivery
16. PEGylated Silica Nanoparticles: Revolutions in Advanced Drug Delivery
17. PEGylated Gold Nanoparticles: Revolutions in Advanced Drug Delivery
18. PEGylated Silver Nanoparticles: Revolutions in Advanced Drug Delivery
19. PEGylated Magnetic Nanoparticles: Revolutions in Advanced Drug Delivery
20. PEGylated Nanocarriers: A New Frontier in Vaccine Delivery
21. PEGylated Nanocarriers: A New Frontier in Gene Delivery
22. Regulatory Concerns, Future Prospects and Concluding Remarks of PEGylated Nanocarriers
Product details
Product details
- Edition: 1
- Latest edition
- Published: April 1, 2027
- Language: English
About the editor
About the editor
Prashant Kesharwani
Editor
Dr. Prashant Kesharwani, PhD, is an Assistant Professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr.
Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research,
and industrial experience across various countries. An overarching goal of his current research is the development of
nanoengineered drug delivery systems for various diseases. He has more than 400 international publications in well-reputed
journals and more than 30 international books (Elsevier). His work has garnered 40,000 + citations, with an h-index of above
100, making him one of the youngest Indian researchers to achieve an h-index of 100 at the age of 41. He is a recipient
of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards,
such as “USERN Laureate award” and “SERB-Ramanujan Fellowship Award.” He has presented many invited talks and oral
presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution,
supervised students/junior researchers, and actively participated in outreach and scientific dissemination for the service of
the wider community.
Affiliations and expertise
Dr. Harisingh Gour Vishwavidyalaya University, India